AliveCor QT Service vs iCAC Device
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if you need to rapidly and accurately assess cardiac safety, particularly concerning medication effects on QT intervals. This tool is ideal for healthcare professionals who require instant, precise QT and QTc measurements from AliveCor 6-Lead ECGs to inform critical medication prescribing decisions and monitor for potential drug-induced arrhythmias.
View AliveCor QT Service →Choose iCAC Device if…
Choose Bunkerhill Health's iCAC Device if your goal is to opportunistically identify and quantify coronary artery calcium from routine, non-contrast chest CT scans. This AI-powered solution is best suited for radiologists and cardiologists seeking to leverage existing imaging data for early cardiovascular disease detection and risk stratification, providing valuable adjunctive information without requiring dedicated cardiac CTs.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | iCAC Device |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Contact for pricing |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iCAC DeviceTool B integrates seamlessly into existing radiology workflows by analyzing routine CT scans and integrating with PACS or DICOM routers. While Tool A integrates with its own ecosystem and offers APIs, it requires the use of specific AliveCor 6-Lead ECG devices, which introduces a hardware dependency not present with Tool B's use of existing imaging data.
Clinical Value
TieBoth tools offer significant and FDA-cleared clinical value in distinct areas of cardiology. Tool A enhances cardiac safety by providing instant QT interval measurements for medication management, while Tool B aids in early cardiovascular disease detection through coronary artery calcium quantification from routine CT scans. Their value propositions are different but equally impactful in their respective clinical contexts.
Pricing & Value
TieNeither tool provides transparent pricing information, both requiring direct contact with the vendor for details. Without access to pricing, it is impossible to conduct a meaningful comparison of their cost-effectiveness or overall value proposition.
Enterprise Readiness
AliveCor QT ServiceTool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, which are fundamental requirements for healthcare enterprise adoption. Tool B, while FDA-cleared and offering integration, requires contacting the vendor for details on HIPAA compliance and BAA, indicating less upfront transparency in these critical areas for enterprise deployment.
Innovation
iCAC DeviceBoth tools leverage AI/deep learning. Tool A provides instant QT measurements from mobile ECGs. However, Tool B's innovation in opportunistically detecting and quantifying coronary artery calcium from *routine, non-contrast, non-gated chest CT scans* that were performed for other reasons is particularly impactful, as it extracts new, vital cardiovascular risk information from existing data without requiring additional procedures or radiation exposure.
Support & Docs
AliveCor QT ServiceAliveCor (Tool A) is a more established company with a broader product ecosystem (Kardia devices, KardiaPro) and a more mature professional support infrastructure, including readily available resources and documentation for its various offerings. Bunkerhill Health (Tool B), while innovative, has less readily available specific support and documentation information for its iCAC Device in public search results, suggesting a potentially less developed support framework.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | iCAC Device |
|---|---|---|
| Name | AliveCor QT Service | iCAC Device |
| Company | AliveCor | Bunkerhill Health |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | Bunkerhill Health's iCAC Device is an FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Key Functionality | Measures QT and QTc intervals from AliveCor 6-Lead ECGs for cardiac safety assessment. | Detects and quantifies coronary artery calcium from routine chest CT scans. |
| Input Data Type | AliveCor 6-Lead ambulatory ECGs | Routine, non-contrast, non-gated chest CT scans |
| Target User | Qualified healthcare professionals (Prescription (Rx) use only) | Radiologists (provides adjunctive information) |
| Integration | KardiaStation app, KardiaPro portal, API for EHR, SDK, CRM, EDC, PSP platforms | EHRs via the Carebricks platform, PACS or DICOM router |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and iCAC Device.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or iCAC Device
Backers
Who funded each tool's parent company.